Top Stories
-
Scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
-
In a new study, Columbia cancer researchers have identified a potential new drug target in lung metastases of esophageal squamous cell carcinoma.
-
Columbia cancer researchers are working to increase the representation of people of color in cancer clinical trials and decrease the health equity gap, with the help of Stand Up to Cancer.
-
Reducing levels of a hormone prevented metastasis and prolonged survival in mice with pancreatic cancer, a study from Columbia has found, which could lead to new treatments for patients.
Latest News
- September 25, 2020
Velocity, Columbia’s annual fundraiser for cancer research, has changed this year, with participants cycling, running, and even sailing to support cancer research and care.
Topic
- August 26, 2020
The Herbert Irving Comprehensive Cancer Center has been redesignated as a Comprehensive Cancer Center by the NCI, the federal government’s principal agency for cancer research, care, and training.
Topic
- August 20, 2020
A study of cancer patients with COVID-19 finds mortality is significantly higher than in the general population and Black patients are half as likely to receive the antiviral remdesivir.
- July 31, 2020
A breast cancer patient explains how her treatment team unflinchingly continued her care during the COVID-19 pandemic.
Topic
- June 10, 2020
Compared to yearly screening, more frequent mammograms for women treated for early-stage breast cancer did not confer additional benefit, a study from Columbia University oncologists has found.
Topic
- April 20, 2020
Seizures are usually considered a side effect of brain cancer, but a new Columbia University study of mice suggests they may also fuel the further growth of brain tumors.
Topic
- April 9, 2020
Columbia University President Lee Bollinger announced the appointment of Anil Rustgi, MD, director of the Herbert Irving Comprehensive Cancer Center, as interim EVP and dean, effective July 1, 2020.
Topic
- April 3, 2020
Scientists at Columbia's Herbert Irving Comprehensive Cancer Center are using technologies developed to study cancer to look for drugs to treat COVID-19 and disarm the virus.
Topic
- April 2, 2020
In a new study of mice, Columbia researchers found that an experimental drug that breaks down an amino acid slows pancreatic tumor growth by causing ferroptosis, an unusual form of cell death.
- March 5, 2020
CancerFIT—a free exercise program at CUIMC for cancer patients and survivors—offers more than a physical workout, it also provides much-needed support and inspiration.
